Clinical Trials | September 23, 2025
Roche's Giredestrant combination meets phase III endpoints in advanced breast cancer
Importantly, the combination of giredestrant and everolimus was well tolerated
Importantly, the combination of giredestrant and everolimus was well tolerated
Keytruda Qlex is the first and only subcutaneously administered immune checkpoint inhibitor that can be given by a health care provider in as little as one minute
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Wegovy achieved significant weight loss with one in three study participants losing 20% or more body weight
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Encouraging early detection and breaking the silence around men’s health
The state-of-the-art facility is a 450-bedded, multi-specialty tertiary care hospital,
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Subscribe To Our Newsletter & Stay Updated
